TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Arthro Therapeutics AB
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 |
| Turnover |
320,541
|
218,832
|
40,548 |
| Financial expenses |
14,068
|
12,216
|
10,096 |
| Earnings before taxes |
-71,986
|
-75,729
|
-123,884 |
| EBITDA |
-9,772
|
-18,817
|
-82,118 |
| Total assets |
187,043
|
194,163
|
271,177 |
| Current assets |
73,215
|
57,592
|
87,134 |
| Current liabilities |
47,674
|
69,065
|
25,066 |
| Equity capital |
-107,262
|
-106,131
|
57,409 |
| - share capital |
614
|
490
|
345 |
| Employees (average) |
191
|
157
|
85 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 |
| Solvency |
-57.3%
|
-54.7%
|
21.2% |
| Turnover per employee |
1,678
|
1,394
|
477 |
| Profit as a percentage of turnover |
-22.5%
|
-34.6%
|
-305.5% |
| Return on assets (ROA) |
-31.0%
|
-32.7%
|
-42.0% |
| Current ratio |
153.6%
|
83.4%
|
347.6% |
| Return on equity (ROE) |
67.1%
|
71.4%
|
-215.8% |
| Change turnover |
97,763
|
175,406
|
-111,248 |
| Change turnover % | 44% | -73% | |
| Chg. No. of employees |
34
|
72
|
5 |
| Chg. No. of employees % | 22% | 6% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.